Stock Analysts’ Price Target Changes for October 8th (ABT, ANET, APOG, AVGO, BSX, CDE, CRBG, DXCM, EAT, EQH)

Stock Analysts’ price target changes for Tuesday, October 8th:

Abbott Laboratories (NYSE:ABT) had its target price raised by Royal Bank of Canada from $125.00 to $130.00. Royal Bank of Canada currently has an outperform rating on the stock.

Arista Networks (NYSE:ANET) had its target price raised by Citigroup Inc. from $385.00 to $460.00. The firm currently has a buy rating on the stock.

Apogee Enterprises (NASDAQ:APOG) had its target price raised by DA Davidson from $65.00 to $75.00. They currently have a neutral rating on the stock.

Broadcom (NASDAQ:AVGO) had its price target boosted by Cantor Fitzgerald from $200.00 to $225.00. They currently have an overweight rating on the stock.

Boston Scientific (NYSE:BSX) had its target price boosted by Royal Bank of Canada from $85.00 to $95.00. Royal Bank of Canada currently has an outperform rating on the stock.

Coeur Mining (NYSE:CDE) had its target price boosted by Canaccord Genuity Group Inc. from $7.00 to $7.75. Canaccord Genuity Group Inc. currently has a buy rating on the stock.

Corebridge Financial (NYSE:CRBG) had its price target boosted by Barclays PLC from $33.00 to $34.00. The firm currently has an equal weight rating on the stock.

DexCom (NASDAQ:DXCM) had its price target reduced by Royal Bank of Canada from $130.00 to $120.00. The firm currently has an outperform rating on the stock.

Brinker International (NYSE:EAT) had its target price increased by Citigroup Inc. from $69.00 to $83.00. They currently have a neutral rating on the stock.

Equitable (NYSE:EQH) had its target price raised by Barclays PLC from $59.00 to $60.00. The firm currently has an overweight rating on the stock.

Edwards Lifesciences (NYSE:EW) had its price target trimmed by Royal Bank of Canada from $85.00 to $75.00. They currently have an outperform rating on the stock.

Chesapeake Energy (NASDAQ:EXE) had its price target raised by Citigroup Inc. from $90.00 to $97.00. Citigroup Inc. currently has a buy rating on the stock.

Freeport-McMoRan (NYSE:FCX) had its target price raised by Scotiabank from $52.00 to $53.00. The firm currently has a sector perform rating on the stock.

F&G Annuities & Life (NYSE:FG) had its target price lowered by Barclays PLC from $45.00 to $44.00. Barclays PLC currently has an equal weight rating on the stock.

GlobalFoundries (NASDAQ:GFS) had its price target lowered by Cantor Fitzgerald from $55.00 to $40.00. The firm currently has a neutral rating on the stock.

Globus Medical (NYSE:GMED) had its target price raised by Royal Bank of Canada from $78.00 to $80.00. Royal Bank of Canada currently has an outperform rating on the stock.

Intuitive Surgical (NASDAQ:ISRG) had its target price boosted by Royal Bank of Canada from $515.00 to $525.00. The firm currently has an outperform rating on the stock.

Johnson & Johnson (NYSE:JNJ) had its price target increased by Royal Bank of Canada from $175.00 to $178.00. They currently have an outperform rating on the stock.

Jackson Financial (NYSE:JXN) had its price target raised by Barclays PLC from $109.00 to $111.00. Barclays PLC currently has an overweight rating on the stock.

Lincoln National (NYSE:LNC) had its price target increased by Barclays PLC from $35.00 to $36.00. Barclays PLC currently has an equal weight rating on the stock.

Medtronic (NYSE:MDT) had its target price increased by Royal Bank of Canada from $92.00 to $98.00. Royal Bank of Canada currently has a sector perform rating on the stock.

NRG Energy (NYSE:NRG) had its price target increased by Guggenheim from $77.00 to $118.00. They currently have a buy rating on the stock.

NXP Semiconductors (NASDAQ:NXPI) had its target price reduced by Cantor Fitzgerald from $350.00 to $270.00. They currently have an overweight rating on the stock.

Penumbra (NYSE:PEN) had its price target raised by Royal Bank of Canada from $205.00 to $222.00. The firm currently has an outperform rating on the stock.

Philip Morris International (NYSE:PM) had its target price raised by Citigroup Inc. from $118.50 to $132.00. They currently have a buy rating on the stock.

QUALCOMM (NASDAQ:QCOM) had its price target cut by Cantor Fitzgerald from $215.00 to $160.00. Cantor Fitzgerald currently has a neutral rating on the stock.

Reinsurance Group of America (NYSE:RGA) had its price target reduced by Barclays PLC from $255.00 to $250.00. Barclays PLC currently has an overweight rating on the stock.

Starbucks (NASDAQ:SBUX) had its price target raised by Citigroup Inc. from $98.00 to $99.00. Citigroup Inc. currently has a neutral rating on the stock.

Teck Resources (NYSE:TECK) (TSE:TECK) had its target price increased by Scotiabank from $78.00 to $79.00. They currently have a sector outperform rating on the stock.

Teleflex (NYSE:TFX) had its target price increased by Royal Bank of Canada from $260.00 to $275.00. Royal Bank of Canada currently has an outperform rating on the stock.

Texas Instruments (NASDAQ:TXN) had its target price lowered by Cantor Fitzgerald from $210.00 to $200.00. They currently have a neutral rating on the stock.

Unum Group (NYSE:UNM) had its target price lowered by Barclays PLC from $73.00 to $72.00. The firm currently has an overweight rating on the stock.

Voya Financial (NYSE:VOYA) had its target price increased by Barclays PLC from $84.00 to $85.00. Barclays PLC currently has an overweight rating on the stock.

Vistra (NYSE:VST) had its target price raised by Guggenheim from $133.00 to $177.00. The firm currently has a buy rating on the stock.

Wendy’s (NASDAQ:WEN) had its target price raised by Citigroup Inc. from $18.00 to $18.75. The firm currently has a neutral rating on the stock.

Zimmer Biomet (NYSE:ZBH) had its target price lowered by Royal Bank of Canada from $130.00 to $120.00. The firm currently has an outperform rating on the stock.

Zynex (NASDAQ:ZYXI) had its target price trimmed by Royal Bank of Canada from $12.00 to $11.00. Royal Bank of Canada currently has an outperform rating on the stock.